Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 40INDUSTRY 25OTHER_GOV 4NETWORK 2

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 1Breast 1

Conditions

Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Sarcopenia 1Ovarian Neoplasms 1Malnutrition 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Dysgeusia 1

Interventions

Cisplatin 49Capecitabine 42Radiotherapy 33Oxaliplatin 33Gemcitabine 33apatinib 32Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 20Nivolumab 19pembrolizumab 18fludarabine 18Metformin 16Exercise 16Radiation 15camrelizumab 14S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER_GOV × CP protocol × Clear all
NCT07154966 2025-09-04

GYM-TASTE

Ankara Etlik City Hospital

Completed
102 enrolled
Gynecologic

Dysgeusia, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Malnutrition, Sarcopenia

NCT03168880 2025-04-09

TNBC

Tata Memorial Hospital

Phase 3 Active not recruiting
720 enrolled
Breast

Triple Negative Breast Neoplasms

NCT02924909 2018-03-20

QUIMERA

Instituto Nacional de Cancer, Brazil

Phase 2 Unknown
50 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT00147680 2012-02-02

Uterine Papillary Serous Cancer (UPSC) Trial

Queensland Centre for Gynaecological Cancer

Phase 2 Completed
30 enrolled
Gynecologic

Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡